Exogenous Glutamine in Respiratory Diseases: Myth or Reality?

Several respiratory diseases feature increased inflammatory response and catabolic activity, which are associated with glutamine depletion; thus, the benefits of exogenous glutamine administration have been evaluated in clinical trials and models of different respiratory diseases. Recent reviews and meta-analyses have focused on the effects and mechanisms of action of glutamine in a general population of critical care patients or in different models of injury. However, little information is available about the role of glutamine in respiratory diseases. The aim of the present review is to discuss the evidence of glutamine depletion in cystic fibrosis (CF), asthma, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), and lung cancer, as well as the results of exogenous glutamine administration in experimental and clinical studies. Exogenous glutamine administration might be beneficial in ARDS, asthma, and during lung cancer treatment, thus representing a potential therapeutic tool in these conditions. Further experimental and large randomized clinical trials focusing on the development and progression of respiratory diseases are necessary to elucidate the effects and possible therapeutic role of glutamine in this setting.

[1]  Yu-Chen Hou,et al.  Glutamine Administration After Sublethal Lower Limb Ischemia Reduces Inflammatory Reaction and Offers Organ Protection in Ischemia/Reperfusion Injury. , 2016, JPEN. Journal of parenteral and enteral nutrition.

[2]  M. Balaan,et al.  Acute Respiratory Distress Syndrome , 2016, Critical care nursing quarterly.

[3]  Dean P. Jones,et al.  Efficacy and Safety of Glutamine-supplemented Parenteral Nutrition in Surgical ICU Patients: An American Multicenter Randomized Controlled Trial , 2016, Annals of surgery.

[4]  L. Koenderman,et al.  Targeting neutrophilic inflammation in severe neutrophilic asthma: can we target the disease‐relevant neutrophil phenotype? , 2015, Journal of leukocyte biology.

[5]  D. Heyland,et al.  Enteral glutamine supplementation in critically ill patients: a systematic review and meta-analysis , 2015, Critical Care.

[6]  L. Gianotti,et al.  Glutamine Supplementation in Intensive Care Patients , 2015, Medicine.

[7]  P. Wischmeyer,et al.  Brief Glutamine Pretreatment Increases Alveolar Macrophage CD163/Heme Oxygenase-1/p38-MAPK Dephosphorylation Pathway and Decreases Capillary Damage but Not Neutrophil Recruitment in IL-1/LPS-Insufflated Rats , 2015, PloS one.

[8]  P. Pelosi,et al.  The Effects of Dasatinib in Experimental Acute Respiratory Distress Syndrome Depend on Dose and Etiology , 2015, Cellular Physiology and Biochemistry.

[9]  C.-H. Lee,et al.  Mechanism of glutamine inhibition of cytosolic phospholipase a2 (cPLA2): Evidence of physical interaction between glutamine‐Induced mitogen‐activated protein kinase phosphatase‐1 and cPLA2 , 2015, Clinical and experimental immunology.

[10]  K. Nagai,et al.  Temporal Changes in Glutaredoxin 1 and Protein S-Glutathionylation in Allergic Airway Inflammation , 2015, PloS one.

[11]  Kechen Ban,et al.  Protection by Enteral Glutamine is Mediated by Intestinal Epithelial Cell Peroxisome Proliferator–Activated Receptor-&ggr; During Intestinal Ischemia/Reperfusion , 2015, Shock.

[12]  L. Gianotti,et al.  Effect of Glutamine Dipeptide Supplementation on Primary Outcomes for Elective Major Surgery: Systematic Review and Meta-Analysis , 2015, Nutrients.

[13]  Garry R. Cutting,et al.  Cystic fibrosis genetics: from molecular understanding to clinical application , 2014, Nature Reviews Genetics.

[14]  J. Wernerman,et al.  Plasma glutamine concentration after intensive care unit discharge: an observational study , 2014, Critical Care.

[15]  P. Kuna,et al.  The Step Further to Understand the Role of Cytosolic Phospholipase A2 Alpha and Group X Secretory Phospholipase A2 in Allergic Inflammation: Pilot Study , 2014, BioMed research international.

[16]  Chih-Cheng Lai,et al.  Glutamine Attenuates Acute Lung Injury Caused by Acid Aspiration , 2014, Nutrients.

[17]  C. Wagner,et al.  Dysregulation of the Glutamine Transporter Slc38a3 (SNAT3) and Ammoniagenic Enzymes in Obese, Glucose-Intolerant Mice , 2014, Cellular Physiology and Biochemistry.

[18]  Y. Chuang,et al.  Short-term glutamine supplementation decreases lung inflammation and the receptor for advanced glycation end-products expression in direct acute lung injury in mice , 2014, BMC Pulmonary Medicine.

[19]  S. Hurd,et al.  World Asthma Day. GINA 2014: a global asthma strategy for a global problem. , 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[20]  D. Heyland,et al.  Parenteral glutamine supplementation in critical illness: a systematic review , 2014, Critical Care.

[21]  P. Pelosi,et al.  Intravenous Glutamine Administration Reduces Lung and Distal Organ Injury in Malnourished Rats With Sepsis , 2014, Shock.

[22]  A. Aydoğan,et al.  The efficacy of oral glutamine in prevention of acute radiotherapy-induced esophagitis in patients with lung cancer , 2013, Contemporary oncology.

[23]  D. Cook,et al.  A randomized trial of glutamine and antioxidants in critically ill patients. , 2013, The New England journal of medicine.

[24]  G. Hwang,et al.  Serum metabolomics reveals pathways and biomarkers associated with asthma pathogenesis , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[25]  S. Im,et al.  Glutamine Suppresses Airway Neutrophilia by Blocking Cytosolic Phospholipase A2 via an Induction of MAPK Phosphatase-1 , 2012, The Journal of Immunology.

[26]  Morten Dahl,et al.  Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. , 2012, American journal of respiratory and critical care medicine.

[27]  E. Topkan,et al.  Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer , 2012, BMC Cancer.

[28]  J. Wernerman,et al.  Glutamine and glutathione at ICU admission in relation to outcome , 2012, Clinical science.

[29]  Jesse M. Platt,et al.  Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability , 2011, Proceedings of the National Academy of Sciences.

[30]  J. Bowtell,et al.  No effect of glutamine ingestion on indices of oxidative metabolism in stable COPD , 2011, Respiratory Physiology & Neurobiology.

[31]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[32]  J. Pérez-Bárcena,et al.  Lack of effect of glutamine administration to boost the innate immune system response in trauma patients in the intensive care unit , 2010, Critical care.

[33]  A. Jemal,et al.  Global Patterns of Cancer Incidence and Mortality Rates and Trends , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[34]  W. Wheaton,et al.  Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity , 2010, Proceedings of the National Academy of Sciences.

[35]  R. Locksley,et al.  Asthma and Allergic Inflammation , 2010, Cell.

[36]  A. Eroğlu.  The Effect of Intravenous Alanyl-Glutamine Supplementation on Plasma Glutathione Levels in Intensive Care Unit Trauma Patients Receiving Enteral Nutrition: The Results of a Randomized Controlled Trial , 2009, Anesthesia and analgesia.

[37]  Jie-shou Li,et al.  Glutamine attenuates lipopolysaccharide-induced acute lung injury. , 2009, Nutrition.

[38]  P. Pelosi,et al.  Intravenous glutamine decreases lung and distal organ injury in an experimental model of abdominal sepsis , 2009, Critical care.

[39]  P. J. Barnes,et al.  Systemic manifestations and comorbidities of COPD , 2009, European Respiratory Journal.

[40]  M. Haida,et al.  Plasma branched-chain amino acid levels and muscle energy metabolism in patients with chronic obstructive pulmonary disease. , 2009, Clinical nutrition.

[41]  Yu-Chen Hou,et al.  Effects of dietary glutamine supplementation on lung injury induced by lipopolysaccharide administration. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[42]  P. Pelosi,et al.  Methylprednisolone improves lung mechanics and reduces the inflammatory response in pulmonary but not in extrapulmonary mild acute lung injury in mice* , 2008, Critical care medicine.

[43]  O. Kalayci,et al.  A comprehensive evaluation of the enzymatic and nonenzymatic antioxidant systems in childhood asthma. , 2008, The Journal of allergy and clinical immunology.

[44]  Dean P. Jones,et al.  Ill Surgical Patients Efficacy of Parenteral Nutrition Supplemented With Glutamine Dipeptide to Decrease Hospital Infections , 2008 .

[45]  Y. S. Kim,et al.  Glutamine preferentially inhibits T‐helper type 2 cell‐mediated airway inflammation and late airway hyperresponsiveness through the inhibition of cytosolic phospholipase A2 activity in a murine asthma model , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[46]  A. Turan,et al.  Glutamine and chronic obstructive pulmonary disease. , 2006, European journal of anaesthesiology.

[47]  P. Déchelotte,et al.  L-alanyl-L-glutamine dipeptide–supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: The French controlled, randomized, double-blind, multicenter study* , 2006, Critical care medicine.

[48]  E. Wouters,et al.  Metabolic effects of glutamine and glutamate ingestion in healthy subjects and in persons with chronic obstructive pulmonary disease. , 2006, The American journal of clinical nutrition.

[49]  C. Vogelmeier,et al.  [Pathogenesis of chronic obstructive pulmonary disease]. , 2006, Der Internist.

[50]  P. D'eufemia,et al.  Neutrophil Glutamine Deficiency in Relation to Genotype in Children with Cystic Fibrosis , 2006, Pediatric Research.

[51]  M. Triggiani,et al.  Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes. , 2005, The Journal of allergy and clinical immunology.

[52]  G. Zimmerman,et al.  Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. , 2005, American journal of respiratory cell and molecular biology.

[53]  P. G. Boelens,et al.  The feeding route (enteral or parenteral) affects the plasma response of the dipetide Ala-Gln and the amino acids glutamine, citrulline and arginine, with the administration of Ala-Gln in preoperative patients , 2005, British Journal of Nutrition.

[54]  N. Serkova,et al.  Glutamine attenuates lung injury and improves survival after sepsis: Role of enhanced heat shock protein expression* , 2005, Critical care medicine.

[55]  E. Broadfield,et al.  Amino acids and asthma: a case-control study , 2004, European Respiratory Journal.

[56]  N. Mauras,et al.  Effects of glutamine and recombinant human growth hormone on protein metabolism in prepubertal children with cystic fibrosis. , 2004, The Journal of clinical endocrinology and metabolism.

[57]  D. Keast,et al.  The haematological, biochemical and immunological profile of athletes suffering from the overtraining syndrome , 2004, European Journal of Applied Physiology and Occupational Physiology.

[58]  P. Wischmeyer,et al.  Prevention of chemotherapy and radiation toxicity with glutamine. , 2003, Cancer treatment reviews.

[59]  C. Mélot,et al.  Function and bulk of respiratory and limb muscles in patients with cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.

[60]  G. Baverel,et al.  Inhibition of Glutamine Synthetase in the Mouse Kidney , 2003, Journal of Biological Chemistry.

[61]  N. Deutz,et al.  Pulmonary glutamine production: effects of sepsis and pulmonary infiltrates , 2003, Intensive Care Medicine.

[62]  R. Curi,et al.  Glutamine and glutamate—their central role in cell metabolism and function , 2003, Cell biochemistry and function.

[63]  S. Antoniu,et al.  Hospitalizations and mortality in the Lung Health Study , 2002, Expert review of pharmacoeconomics & outcomes research.

[64]  N. Mauras,et al.  Can Glutamine and Growth Hormone Promote Protein Anabolism in Children with Cystic Fibrosis? , 2002, Hormone Research in Paediatrics.

[65]  B. Wiedemann,et al.  Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project. , 2002, Thorax.

[66]  H. O. Oudemans-van Straaten,et al.  Plasma glutamine depletion and patient outcome in acute ICU admissions , 2001, Intensive Care Medicine.

[67]  E. Wouters,et al.  Altered glutamate metabolism is associated with reduced muscle glutathione levels in patients with emphysema. , 2000, American journal of respiratory and critical care medicine.

[68]  W. Chang,et al.  Lymphocyte proliferation modulated by glutamine: involved in the endogenous redox reaction , 1999, Clinical and experimental immunology.

[69]  W. Souba,et al.  Glutamine synthetase expression in rat lung is regulated by protein stability. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[70]  E. Wouters,et al.  Plasma and muscle amino acid levels in relation to resting energy expenditure and inflammation in stable chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[71]  R. Curi,et al.  Glutamine utilization by rat neutrophils: presence of phosphate-dependent glutaminase. , 1997, The American journal of physiology.

[72]  W. Souba,et al.  Regulation of glutamine synthetase in human breast carcinoma cells and experimental tumors. , 1997, Surgery.

[73]  G. J. van der Vusse,et al.  Deamination of amino acids as a source for ammonia production in human skeletal muscle during prolonged exercise. , 1995, The Journal of physiology.

[74]  W. Souba,et al.  Inhibition of pulmonary microvascular endothelial glutamine transport by glucocorticoids and endotoxin. , 1995, JPEN. Journal of parenteral and enteral nutrition.

[75]  K. Bland,et al.  Influence of Progressive Tumor Growth on Glutamine Metabolism in Skeletal Muscle and Kidney , 1993, Annals of surgery.

[76]  K. Bland,et al.  Mechanisms of accelerated hepatic glutamine efflux in the tumour-bearing rat. , 1992, Surgical oncology.

[77]  K. Bland,et al.  Tumor regulation of hepatic glutamine metabolism. , 1991, JPEN. Journal of parenteral and enteral nutrition.

[78]  W. Souba,et al.  Lung glutamine metabolism. , 1990, JPEN. Journal of parenteral and enteral nutrition.

[79]  K. Bland,et al.  Glutamine-enriched diets support muscle glutamine metabolism without stimulating tumor growth. , 1990, The Journal of surgical research.

[80]  W. Souba,et al.  Accelerated lung amino acid release in hyperdynamic septic surgical patients. , 1990, Archives of surgery.

[81]  C. Scrimgeour,et al.  Muscle wasting in emphysema. , 1988, Clinical science.

[82]  J. Minna,et al.  Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. , 1986, Cancer research.

[83]  M. Schemper,et al.  Metabolic disorders in severe abdominal sepsis: glutamine deficiency in skeletal muscle. , 1982, Clinical nutrition.

[84]  P. Fürst,et al.  Influence of the Postoperative State on the Intracellular Free Amino Acids in Human Muscle Tissue , 1975, Annals of surgery.